Latest news
Find out more about our work by reading our latest news stories and insight articles.
Market Shapers interview series
Publications
Featured article
31 October 2025
New interview series explores the science, art and impact of market shaping
MedAccess is pleased to announce the launch of Market Shapers, a new video interview series that brings together some of the most influential voices in global health to explore how market shaping works, why it matters and where it’s heading. Market shaping is familiar to many in global health, but its inner workings are often complex and misunderstood. Market Shapers aims to…
Read moreFilter stories

1 December 2021 | Insight
HIV viral load testing: “If we could test more often, we would”
HIV viral load testing is the best way for doctors to know if the treatment they prescribe is effective. But…

16 November 2021 | Insight
Five things you should know about the new partnership to increase access to dual HIV/syphilis testing
On November 15, the Clinton Health Access Initiative (CHAI), MedAccess, and SD Biosensor announced a partnership to increase access to…

15 November 2021 | News
New partnership to increase access to dual rapid testing for syphilis and HIV
MedAccess, CHAI and SD Biosensor announce partnership to make dual rapid test for syphilis and HIV available for under US$1…

19 October 2021 | Insight
“I know first-hand the importance of patient-friendly TB treatment”
Evans Mburu, our implementation executive, knows first-hand TB’s devastating impact. When Evans was a student at Jomo Kenyatta University, he…

8 October 2021 | Insight
The importance of tackling resistance in mosquitos
The longer a mosquito population is exposed to a single class of insecticides, the longer it has had to build…

13 September 2021 | News
MedAccess welcomes Vicky Johnson as new Chief Financial Officer
Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess’ Senior Management Team. MedAccess…

16 August 2021 | News
Improving availability of patient-friendly tuberculosis preventive therapy
MedAccess’ volume guarantee will help increase availability of an innovative treatment for latent tuberculosis. Global partners working to tackle the…

4 August 2021 | News
New financing agreement boost for malaria vaccine
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead…

7 July 2021 | Insight
Getting new malaria control technologies to communities
New malaria control technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how…